(Total Views: 319)
Posted On: 01/29/2017 10:43:57 PM
Post# of 405
FWIW - I do believe that PPS will start a nice run (beginning 1/30). I say this for 3 main reasons folks:
- Earnings are coming soon and they will BEAT the guidance of $5M in revenue for all of 2016. No question
- Novalere CANNOT sell shares until at least 4/1/17 and they have some 25M. So you might as well subtract Damaj's, Novalere's, and the board's sharecount from the current o/s as they will not be selling/dumping near term (several months) Damaj is not going to screw over his CFO (Robert) and friend and brand new EVP Randy B.
- Little talked about point, but Q2 (Spring) is the PRIME time frame for nasal allergy relief sales. I strongly doubt that FlutiCare approval will come after 2/15 as they need time to get it on store shelves to be available for allergy season. I think they can salvage almost all of the 2nd QTR for this product IF FDA approval comes inside of the next 3 weeks. I am quite sure Damaj knows this and is doing whatever he can to hit the ground running, once approved.
- Earnings are coming soon and they will BEAT the guidance of $5M in revenue for all of 2016. No question
- Novalere CANNOT sell shares until at least 4/1/17 and they have some 25M. So you might as well subtract Damaj's, Novalere's, and the board's sharecount from the current o/s as they will not be selling/dumping near term (several months) Damaj is not going to screw over his CFO (Robert) and friend and brand new EVP Randy B.
- Little talked about point, but Q2 (Spring) is the PRIME time frame for nasal allergy relief sales. I strongly doubt that FlutiCare approval will come after 2/15 as they need time to get it on store shelves to be available for allergy season. I think they can salvage almost all of the 2nd QTR for this product IF FDA approval comes inside of the next 3 weeks. I am quite sure Damaj knows this and is doing whatever he can to hit the ground running, once approved.
(1)
(0)
